About Dr. Jeffrey Braverman
Dr. Braverman is the founder and Medical Director at Braverman Reproductive Immunology with offices in Long Island and Manhattan. He has formerly held the position of Medical Director of SIRM on Long Island.
Dr. Braverman was honored as the youngest graduate at New York University where he was accepted at the age of 14. He went on to attend Medical School at The Mount Sinai Medical Center in Manhattan and completed his internship and residency at the Albert Einstein School of Medicine in New York.
After completing his residency Dr. Braverman established a private medical practice in Long Island New York. For more than 20 years, Dr. Braverman has been treating patients with all complications related to Recurrent Pregnancy Loss and has become one of the nation's leading authorities in the field Reproductive Immunology. He has managed thousands of cycles of IUI and IVF with a large majority of his patients suffering from Recurrent Pregnancy Loss and Failure to initiate and Successfully Complete a Pregnancy (RPL and FISCP). He has consistently maintained one of the highest success rates in New York despite the complexity of his case load. For the last three years in a row, his practice was voted the Best Infertility Practice on Long Island in an independent poll conducted by the Long Island Press.
Dr. Braverman has published articles in the field of high risk obstetrics related to IUGR, Gestational Diabetes, and Fetal Distress and has gained unequaled experience managing as well as delivering this High Risk group of patients. In fact Dr. Braverman has delivered well over 5000 babies in his career. He has been featured with his RPL autoimmune patients on Discovery Channels Baby Story, local TV news stations, and has hosted numerous radio shows on reproductive immunology and fertility.
He assists and consults with patients from around the world with problems related to RPL and FISCP. He has designed the most complete panel for the diagnosis and management of immune related pregnancy complications, as well as one of the most comprehensive thrombophilia (blood clotting) panels available. He is currently assisting in designing a computer chip that will test DNA for most of the known genetic defects (hundreds) associated with RPL. He assisted in the Fertility Project for the development of nutritional supplements now used for the treatment of RPL and FISCP.
His current office staff has all been part of this practice for at least 20 years and most, longer than that. This has also been one of the most important elements in maintaining our consistency. You will always get someone knowledgeable when you call the office. Dr. Braverman performs all his own consults and sonograms. You will never get a "fill in "when you call for a consult or come in for a visit. He manages every case from start to finish. Most have his cell phone number and email and feel free to contact him with any questions. Many of Dr. Braverman's patients from around the country learn about him in numerous immunology and fertility chat rooms on the internet, where he has developed a loyal following.
Dr. Braverman is a member in good standing with the American Society of Reproductive Immunology, the American Society of Reproductive Medicine, the European Society of Reproductive Immunology, the American College of Obstetrics and Gynecology, the New York State Medical Society, the Nassau County Medical Society and is actively Board Certified from the American Board of Obstetrics and Gynecology.
About Dr. Darren Ritsick
Darren Ritsick, Ph.D. joined Braverman Reproductive Immunology as Director of Research earlier this year. Darren and his wife Maggie personally struggled with recurrent pregnancy loss for more than two years prior to discovering Dr. Braverman. Happily, under Dr. Braverman's care they are now well on their way to realizing their dream of becoming parents and look forward to meeting their new little one soon.
Through our interactions with Dr. Ritsick as a patient, it became clear that he possesses a vast knowledge of reproductive immunology as well as a sincere passion to help others experiencing the pain and frustration associated with recurrent pregnancy loss. As Director of Research he will be involved in helping to further improve and advance our highly personalized approach to diagnosis and therapy. This will include performing sophisticated analyses of diagnostic tests and therapeutic approaches currently in use, as well as helping us to identify, develop and implement the next generation of diagnostic and therapeutic approaches in reproductive immunology.
Dr. Ritsick received a B.S. in Biology from the University of Richmond, graduating cum laude with Departmental Honors in Biology. While studying as an undergraduate, he conducted research on the genetic basis of brain tumor development and completed an internship at the Center for Immunotherapy of Cancer and Infectious Diseases at the University of Connecticut Health Sciences Center. Dr. Ritsick then went on to earn a Ph.D. in Biochemistry, Cell and Developmental Biology from Emory University for his research on novel biological roles for reactive oxygen species. His research involved an interdisciplinary approach including genetics, cell and molecular biology, and biochemistry. His doctoral work was partially supported by a training grant from the National Institutes of Health and resulted in six publications in peer-reviewed journals and presentations at several large scientific conferences.
After receiving his Ph.D., Dr. Ritsick served as a Scientific Advisor at a patent law firm where he participated in various aspects of patent prosecution in the areas of biotechnology and pharmaceuticals. He worked for a diverse client base including universities, early stage biotechnology companies, investors in early stage biotechnology companies, and larger pharmaceutical companies. A major part of his work was focused on a biotechnology company developing novel immunomodulatory therapeutics designed to treat autoimmune diseases and cancer.
Most recently Dr. Ritsick served as Senior Research Project Coordinator in the Department of Neurosurgery at Emory University where he was involved in grant preparation and administration and served as coordinator for the Cancer Cell Biology Program of the Winship Cancer Institute.
Cassidy Bommer joined Braverman Reproductive Immunology as a Clinical Research Assistant in the fall of 2013. Cassidy graduated cum laude with Honors from Mount Holyoke College with a B.A. in Biological Sciences and a certificate in Culture, Health, and Science.
Cassidy's interest in reproductive health and pregnancy was sparked by a high school internship with Lifebank USA, the only company to offer both cord and placenta blood banking for newborns. She went on to work as a research assistant in the Reproductive Immunology lab of Dr. Sarah J. Bacon at Mount Holyoke College, studying the post-mating inflammatory response during pregnancy in mammals.
During her time as an undergraduate, Cassidy served as a research intern at University Hospital in Newark, NJ in the Obstetrics & Gynecology department, assisting in the development of a series of case reports on the treatment of uterine fibroids during pregnancy. She was also lucky enough to travel to El Salvador with Basic Health International where she participated in cervical cancer screenings for women in various low resource regions of the country.
While studying at Harvard University during her junior year, Cassidy's essay, "The value of the Darwin & Gender project, addressed to the National Science Foundation," was selected for publication on the Darwin Correspondence Project (University of Cambridge) website. Her senior honors thesis, advised by Mount Holyoke College President Lynn Pasquerella, addressed models of perinatal support for women in the Massachusetts criminal justice system. While this work deviated from Cassidy's background in basic and clinical research, it provided her with a launching point for her interest in a woman's "right to pregnancy."
Cassidy is excited to be working with Dr. Braverman, Dr. Ritsick, and the entire team at BRI.